The role of clozapine in treatment-resistant schizophrenia

JAMA Psychiatry

Volumn 73, Issue 3, 2016, Pages 187-188

  Kane, John M ^a,b,c   Correll, Christoph U ^a,b,c  

^a ZUCKER HILLSIDE HOSPITAL   (United States)

^b DONALD AND BARBARA ZUCKER SCHOOL OF MEDICINE AT HOFSTRA NORTHWELL   (United States)

^c FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLOZAPINE; OLANZAPINE; RISPERIDONE; NEUROLEPTIC AGENT;

ALGORITHM; DRUG EFFICACY; EDITORIAL; HUMAN; HYPERSALIVATION; MAINTENANCE THERAPY; MEDICATION COMPLIANCE; META ANALYSIS (TOPIC); PLACEBO EFFECT; RANDOMIZED CONTROLLED TRIAL (TOPIC); SCHIZOPHRENIA; SHORT COURSE THERAPY; TREATMENT FAILURE; TREATMENT RESISTANT SCHIZOPHRENIA; TREATMENT RESPONSE; DRUG RESISTANCE; FEMALE; MALE; PATIENT ATTITUDE;

ANTIPSYCHOTIC AGENTS; DRUG RESISTANCE; FEMALE; HUMANS; MALE; PATIENT ACCEPTANCE OF HEALTH CARE; SCHIZOPHRENIA;

EID: 84962624428     PISSN: 2168622X     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamapsychiatry.2015.2966     Document Type: Editorial

References (7)

1. SamaraMT, DoldM, Gianatsi M, et al. Efficacy, acceptability, and tolerability of antipsychotics in treatment-resistant schizophrenia: a network meta-analysis [published online February 3, 2016]. JAMA Psychiatry. doi:10.1001/jamapsychiatry .2015.2955.
2. Kane J, Honigfeld G, Singer J, Meltzer H. Clozapine for the treatment-resistant schizophrenic: a double-blind comparison with chlorpromazine. Arch Gen Psychiatry. 1988;45(9): 789-796.
3. Leucht S, Cipriani A, Spineli L, et al. Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis. Lancet. 2013;382(9896):951-962.
4. Agid O, Arenovich T, Sajeev G, et al. An algorithm-based approach to first-episode schizophrenia: response rates over 3 prospective antipsychotic trials with a retrospective data analysis. J Clin Psychiatry. 2011;72(11):1439-1444.
5. McEvoy JP, Lieberman JA, Stroup TS, et al; CATIE Investigators. Effectiveness of clozapine versus olanzapine, quetiapine, and risperidone in patients with chronic schizophrenia who did not respond to prior atypical antipsychotic treatment. Am J Psychiatry. 2006;163(4):600-610.
6. Kane JM, Kishimoto T, Correll CU. Assessing the comparative effectiveness of long-acting injectable vs oral antipsychotic medications in the prevention of relapse provides a case study in comparative effectiveness research in psychiatry. J Clin Epidemiol. 2013;66(8)(suppl):S37-S41.
7. Nielsen J, Nielsen RE, Correll CU. Predictors of clozapine response in patients with treatment-refractory schizophrenia: results from a Danish Register Study. J Clin Psychopharmacol. 2012;32(5):678-683.